Pacific Biosciences of California, Inc. (FRA:P09)

FRA:P09 Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	504	520	2,374	1,731	3,969	3,951
Market Cap Growth	-7.83%	-78.08%	37.15%	-56.39%	0.45%	463.66%
Enterprise Value	851	955	2,526	1,837	3,857	3,816
Last Close Price	1.72	1.77	8.86	7.74	17.16	19.80
PE Ratio	-	-	-	-	-	164.37
PS Ratio	3.82	3.50	13.08	14.42	34.58	61.26
PB Ratio	16.37	1.06	3.74	3.29	5.71	14.41
P/TBV Ratio	-	-	-	-	-	14.41
P/FCF Ratio	-	-	-	-	-	261.74
P/OCF Ratio	-	-	-	-	-	247.80
EV/Sales Ratio	6.41	6.42	13.93	15.30	33.61	59.16
EV/FCF Ratio	-7.91	-	-	-	-	252.78
Debt / Equity Ratio	19.48	1.33	1.33	1.69	1.21	0.13
Debt / FCF Ratio	-	-	-	-	-	2.28
Asset Turnover	0.14	0.10	0.11	0.07	0.11	0.28
Inventory Turnover	1.62	1.84	2.66	2.00	3.68	3.36
Quick Ratio	5.21	6.30	7.03	3.00	14.90	8.72
Current Ratio	6.24	7.48	7.81	3.24	15.36	9.24
Return on Equity (ROE)	-205.90%	-51.30%	-48.53%	-46.42%	-32.17%	15.06%
Return on Assets (ROA)	-32.23%	-12.08%	-11.04%	-10.10%	-9.20%	-23.22%
Return on Capital (ROIC)	-34.37%	-12.91%	-12.33%	-11.70%	-10.49%	-26.41%
Return on Capital Employed (ROCE)	-78.50%	-24.30%	-18.80%	-20.30%	-9.20%	-27.80%
Earnings Yield	-85.25%	-57.53%	-11.69%	-16.99%	-4.01%	0.61%
FCF Yield	-21.37%	-39.41%	-10.21%	-15.14%	-2.60%	0.38%
Buyback Yield / Dilution	-9.13%	-8.22%	-12.95%	-10.00%	-16.67%	-14.71%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.